Broker Tips
Wise 'hard to match' on price and speed, says Numis
Numis has upgraded its forecasts and retained its 'buy' stance on foreign exchange platform Wise after a stronger-than-expected start to the new financial year.
Broker tips: JD Sports, B&M, Diageo, Reckitt
RBC Capital Markets has reiterated its positive stance on AB Foods, JD Sports, WH Smith and B&M, saying that consumer buying behaviour in the US paints a promising picture for the London-listed value retailers.
Berenberg lifts targets for Glanbia on margin growth
Berenberg has raised its target price for Glanbia after the Irish performance nutrition and food manufacturer's forecast-beating interim results last week, as strong margins make up for declining volumes.
JPMorgan picks three UK defensive stocks to watch
JPMorgan has kept its 'overweight' rating on UK-listed consumer goods and staples stocks Diageo, Reckitt Benckiser and Imperial Brands, saying the companies are "well positioned" going into the second half of the year.
Discount retailers ABF and B&M to 'outperform', says RBC
RBC Capital Markets has reiterated its positive stance on AB Foods, JD Sports, WH Smith and B&M, saying that consumer buying behaviour in the US paints a promising picture for the London-listed value retailers.
UK banking stocks are undervalued, says Shore Capital
Shore Capital has reiterated its ‘buy’ ratings on six UK-listed banking stocks, saying the market is currently pricing in a “far worse outlook”.
Ball Aerospace buy puts BAE in solid position, says Shore Capital
BAE Systems was trading with heavy losses on Thursday after the news that it has acquired Ball Aerospace – a move which broker Shore Capital viewed as a vote of confidence for the wider defence industry.
Broker tips: Analysts positive on CAB Payments and Trainline
Canaccord Genuity expects shares of CAB Payments to more than double from current levels, as it kicked off coverage of the stock with a ‘buy’ rating.
Canaccord sees huge upside at CAB Payments
Canaccord Genuity expects shares of CAB Payments to more than double from current levels, as it kicked off coverage of the stock with a ‘buy’ rating.
Trainline's discount to the market "unwarranted", says Shore Capital
Trainline is being undervalued by the market, according to broker Shore Capital, which sees huge upside for shares of the rail and coach booking platform.
Just Group to 'outperform' after H1 beat
RBC Capital Markets sees significant upside in the shares of retirement financial services firm Just Group after the company smashed expectations with its first-half results.
M&S shares have further to run, says Shore Capital
Shares in Marks & Spencer jumped on Tuesday after the high street retailer lifted guidance for the year, which house broker Shore Capital said should result in a significant upgrade to consensus forecasts.
Berenberg cuts Lancashire target, but keeps at 'buy'
Berenberg has reduced its target price for the shares of Lancashire Holdings, but has maintained its positive stance on the Bermuda-based insurance group.
Broker tips: Analysts upbeat about OneSavings Bank and Capita
The share price of Capita was given a much-needed boost on Friday morning after Shore Capital upgraded its rating on the business process outsourcing company from 'hold' to 'buy'.
Berenberg ups target for OSB despite H1 woes
The recent rebound in shares of OneSavings Bank (OSB) could have further to run, according to Berenberg, which upped its target price on the stock on Friday.
Shore Capital upgrades Capita to 'buy', sees 50% upside
The share price of Capita was given a much-needed boost on Friday morning after Shore Capital upgraded its rating on the business process outsourcing company from 'hold' to 'buy'.
Broker tips: Antofagasta, Spirax-Sarco, Smith & Nephew
Canaccord Genuity has maintained its 'buy' recommendation on miner Antofagasta despite the firm cutting its output forecasts on Thursday.
Canaccord optimistic on Antofagasta's H2 output
Canaccord Genuity has maintained its 'buy' recommendation on miner Antofagasta despite the firm cutting its output forecasts on Thursday.
Major upside potential at Smith & Nephew, says Berenberg
Berenberg has kept its 'buy' rating on Smith & Nephew after the medical equipment manufacturer's first-half results last week, giving an optimistic take on its current turnaround strategy.
Spirax-Sarco shares "fully valued" after H1 miss, says Shore Capital
Shore Capital has reiterated its 'hold' stance on shares of Spirax-Sarco after the company disappointed the market with its first-half results, saying the stock is "full valued" for now.